S. Mulé

发表

A rapid, quantitative GLC method for the simultaneous determination of nicotine and cotinine.

J. Jaffe, M. Kanzler, K. Verebey, 1982, Journal of analytical toxicology.

Confirmation and quantitation of cocaine, benzoylecgonine, ecgonine methyl ester in human urine by GC/MS.

S. Mulé, G. Casella, 1988, Journal of analytical toxicology.

Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening.

S. Mulé, G. Casella, 1988, Journal of analytical toxicology.

Quantitative determination of benzoylecgonine and cocaine in human biofluids by gas-liquid chromatography.

K. Verebey, A. DePace, S. Mulé, 1977, Analytical chemistry.

Evaluation of immunoassay methods for detection, in urine, of drugs subject to abuse.

S. Mulé, M. L. Bastos, D. Jukofsky, 1974, Clinical chemistry.

Physiological disposition and biotransformation of (3H) cocaine in acutely and chronically treated rats.

P. Nayak, S. Mulé, A. Misra, 1976, The Journal of pharmacology and experimental therapeutics.

Naltrexone: Disposition, metabolism, and effects after acute and chronic dosing

J. Volavka, K. Verebey, S. Mulé, 1976, Clinical pharmacology and therapeutics.

Laboratory Testing in the Diagnosis of Marijuana Intoxication and Withdrawal

M. Gold, K. Verebey, S. Mulé, 1986 .

Active and realistic passive marijuana exposure tested by three immunoassays and GC/MS in urine.

P. Lomax, S. Mulé, S. Gross, 1988, Journal of analytical toxicology.

Evaluation of the radioimmunoassay for benzoylecgonine (a cocaine metabolite) in human urine.

K. Verebey, S. Mulé, M. Kogan, 1977, Clinical chemistry.

The Pharmacodynamics of Cocaine Abuse

S. Mulé, 1984 .

Physiological disposition and metabolism of levo-methadone-1- 3 H in nontolerant and tolerant rats.

R. Bloch, S. Mulé, A. Misra, 1973, The Journal of pharmacology and experimental therapeutics.

Cocaine: tolerance to its convulsant and cardiorespiratory stimulating effects in the monkey.

M. Matsuzaki, S. Mulé, A. Misra, 1976, Life sciences.

Radioimmunoassay of drugs subject to abuse: critical evaluation of urinary morphine-barbiturate, morphine, barbiturate, and amphetamine assays.

S. Mulé, D. Jukofsky, E. Whitlock, 1975, Clinical chemistry.

Physiological Disposition of Narcotic Agonists and Antagonists

S. Mulé, 1971 .

Evidence for a new metabolite of morphine-N-methyl-14C in the rat.

S. Mulé, A. Misra, N. L. Vadlamani, 1973, Biochemical pharmacology.

Persistence of Methadone-3H and Metabolite in Rat Brain after a Single Injection and its Implications on Pharmacological Tolerance

S. Mulé, A. Misra, 1972, Nature.

Determination of Narcotic Analgesics in Human Biological Materials. Application of Ultraviolet Spectrophotometry, Thin Layer and Gas Liquid Chromatography.

S. Mulé, 1964 .

Routine identification of drugs of abuse in human urine. II. Development and application of the XAD-2 resin column method.

E. Saffer, S. Mulé, M. L. Bastos, 1971, Journal of chromatography.

Semiautomated fluorometric assay for submicrogram quantities of morphine and quinine in human biological material.

S. Mulé, P. L. Hushin, 1971, Analytical chemistry.

Routine identification of drugs of abuse in human urine. I. Application of fluorometry, thin-layer and gas-liquid chromatography.

S. Mulé, 1971, Journal of chromatography.

Identification of narcotics, barbiturates, amphetamines, tranquilizers and psychotomimetics in human urine.

S. Mulé, 1969, Journal of chromatography.

The metabolic fate of H3-cyclazocine in dogs.

C. Gorodetzky, S. Mulé, T. Clements, 1968, The Journal of pharmacology and experimental therapeutics.

Distribution of N-C-14-methyl labeled morphine. I. In central nervous system of nontolerant and tolerant dogs.

L. A. Woods, S. Mulé, 1962, The Journal of pharmacology and experimental therapeutics.

Routine identification of cocaine metabolites in human urine

S. Mulé, M. L. Bastos, D. Jukofsky, 1974 .

Qualitative differentiation between cocaine, lidocaine and cocaine-lidocaine mixtures ("rock-cocaine") using thin-layer chromatography.

K. Verebey, S. Mulé, D. Jukofsky, 1980, Journal of Chromatography A.

THE CHROMATOGRAPHIC SEPARATION OF POLYPHOSPHOINOSITIDES AND STUDIES ON THEIR TURNOVER IN VARIOUS TISSUES.

C. Redman, L. Hokin, S. Mulé, 1964, Biochimica et biophysica acta.

A new phosphoinositide containing four phosphates per inositol.

L. Hokin, S. Mulé, E. SANTIAGO-CALVO, 1963, Biochimica et biophysica acta.

Distribution of N-C-14-methyl labeled morphine. II. Effect of nalorphine in the central nervous system of nontolerant dogs and observations on metabolism.

S. Mulé, Woodsla, Mellettlb, 1962, The Journal of pharmacology and experimental therapeutics.

DISTRIBUTION OF N-C14-METHYL LABELED MORPHINE. 3. EFFECT OF NALORPHINE IN THE CENTRAL NERVOUS SYSTEM AND OTHER TISSUES OF TOLERANT DOGS.

S. Mulé, 1965, The Journal of pharmacology and experimental therapeutics.

Cocaine: Distribution and Metabolism in Animals

S. Mulé, A. Misra, 1977 .

Estimation and disposition of [3H]benzoylecgonine and pharmacological activity of some cocaine metabolites

R. Bloch, P. Nayak, S. Mulé, 1975, The Journal of pharmacy and pharmacology.

Morphine and the incorporation of 32-orthophosphate in vivo into phospholipids of the guinea pig cerebral cortex, liver and subcellular fractions.

S. Mulé, 1970, Biochemical pharmacology.

Morphine and the incorporation of Pi32 into brain phospholipids of nontolerant, tolerant and abstinent guinea pigs.

S. Mulé, 1967, The Journal of pharmacology and experimental therapeutics.

Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment

J. Volavka, S. Mulé, R. Resnick, 1975, Clinical pharmacology and therapeutics.

Naltrexone pharmacology, pharmacokinetics, and metabolism: current status.

K. Verebey, S. Mulé, 1975, The American journal of drug and alcohol abuse.

Amphetamines and Related Stimulants: Chemical, Biological, Clinical, and Sociological Aspects

J. Caldwell, S. Mulé, 1980 .

Confirmation and quantitation of barbiturates in human urine by gas chromatography/mass spectrometry.

S. Mulé, G. Casella, 1989, Journal of analytical toxicology.

Phencyclidine-induced stereotypy in rats: Effects of methadone, apomorphine, and naloxone

K. Verebey, S. Mulé, M. Kogan, 2004, Psychopharmacology.

1-alpha-acetylmethadol(LAAM) pharmacokinetics and metabolism: current status.

S. Mulé, A. Misra, 1975, The American journal of drug and alcohol abuse.

Perextraction, a procedure to extract C21 steroids from tissues and blood.

U. Westphal, S. Mulé, F. Devenuto, 1958, Archives of biochemistry and biophysics.

Modifications of the XAD-2 resin column method for the extraction of drugs of abuse from human urine.

E. Saffer, S. Mulé, M. L. Bastos, 1972, Journal of chromatography.

Quantitative determination of naltrexone and betanaltrexol in human plasma using electron capture detection

K. Verebey, A. DePace, S. Mulé, 1976 .

Quantitative determination of 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN), naltrexone, and 6 beta-naltrexol in human plasma, red blood cells, saliva, and urine by gas liquid chromatography.

J. Volavka, K. Verebey, S. Mulé, 1980, Journal of analytical toxicology.

Naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol plasma levels in schizophrenic patients after large oral doses of naltrexone.

K. Verebey, S. Mulé, 1979, NIDA research monograph.

Isolation and identification of a new metabolite of naltrexone in human blood and urine.

S. Mulé, D. Rosenthal, K. Verebely, 1975, Research communications in chemical pathology and pharmacology.

Inhibition of phospholipid-facilitated calcium transport by central nervous system-acting drugs.

S. Mulé, 1969, Biochemical pharmacology.

Intracellular disposition of H3-morphine in the brain and liver of nontolerant and tolerant guinea pigs.

S. Mulé, J. Flesher, C. Redman, 1967, The Journal of pharmacology and experimental therapeutics.

Effect of morphine and nalorphine on the metabolism of phospholipids in guinea pig cerebral cortex slices.

S. Mulé, 1966, The Journal of pharmacology and experimental therapeutics.

Routine identification of drugs of abuse in human urine. 3. Differential elution of the XAD-2 resin.

S. Mulé, M. L. Bastos, D. Jukofsky, 1973, Journal of chromatography.

Separation of cocaine, some of its metabolites and congeners on glass fibre sheets.

S. Mulé, A. Misra, R. Pontani, 1972, Journal of Chromatography A.

Identification of norcocaine as a metabolite of [3H]-cocaine in rat brain

P. Nayak, M. Patel, S. Mulé, 1974, Experientia.

[3H]-Norcocaine and [3H]-pseudococaine: Effect of N-demethylation and C2-epimerization of cocaine on its pharmacokinetics in the rat

S. Mulé, A. Misra, R. Pontani, 2005, Experientia.

Disposition and metabolism of [3H]cocaine in acutely and chronically treated dogs.

P. Nayak, M. Patel, S. Mulé, 1976, Xenobiotica; the fate of foreign compounds in biological systems.

In vivo Formation of Normorphine in the Rat as a Metabolite of Tritium Nuclear-labelled Morphine

L. A. Woods, S. Mulé, A. Misra, 1961, Nature.

Chemical & Biological Aspects of Drug Dependence

S. Mulé, H. Brill, 1972 .

Simultaneous determination of nicotine and cotinine in human plasma by nitrogen detection gas-liquid chromatography.

K. Verebey, S. Mulé, M. Kogan, 1981, Journal of forensic sciences.

Quantitation and confirmation of the diazolo- and triazolobenzodiazepines in human urine by gas chromatography/mass spectrometry.

S. Mulé, G. Casella, 1989, Journal of analytical toxicology.

Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.

R. Bloch, S. Mulé, J. Vardy, 1976, Drug metabolism and disposition: the biological fate of chemicals.

Determination of 6-β-naltrexol and naltrexone by bonded-phase adsorption thin-layer chromatography

M. Lehrer, K. Verebey, S. Mulé, 1986 .

A gas-liquid chromatographic method for the determination of naltrexone and beta-naltrexol in human urine.

S. Mulé, D. Jukofsky, K. Verebely, 1975, Journal of chromatography.

PHARMACOLOGY OF ℓ‐α‐ACETYLMETHADOL (LAAM) IN SUBHUMAN PRIMATES *

S. Mulé, A. Misra, 1978 .

Pharmacology of l-alpha-acetylmethadol (LAAM) in subhuman primates.

S. Mulé, A. Misra, 1978, Annals of the New York Academy of Sciences.

Severe Toxicity and Lethality in some Monkeys Following Chronic Administration of -α-Acetylmethadol (LAAM)

S. Mulé, A. Misra, 1977 .

Quantitation of l-alpha-acetylmethadol and its metabolites in human serum by capillary gas-liquid chromatography and nitrogen detection.

K. Verebey, A. DePace, S. Mulé, 1985, Journal of chromatography.

Pharmacokinetics and metabolism of (—)‐α‐[2‐3H]acetylmethadol (LAAM) in the monkey: evidence for a new metabolite

R. Bloch, S. Mulé, J. Vardy, 1976, The Journal of pharmacy and pharmacology.

Estimation of 1-alpha(2-3H)acetylmethadol in biological materials and its separation from some metabolites and congeners on glass fibre sheets.

R. Bloch, S. Mulé, A. Misra, 1975, Journal of chromatography.

(2-14C) amobarbital metabolism in tolerant rats.

S. Mulé, A. Misra, R. Pontani, 1974, Xenobiotica; the fate of foreign compounds in biological systems.

Pharmacokinetics and metabolism of (3H) thebaine.

S. Mulé, A. Misra, R. Pontani, 1974, Xenobiotica; the fate of foreign compounds in biological systems.

Physiologic disposition of H3-cyclazocine in nontolerant, tolerant and abstinent dogs.

C. Gorodetzky, S. Mulé, 1966, The Journal of pharmacology and experimental therapeutics.

Physiological disposition and biotransformation of levo-methandone-1-3H in the dog.

R. Bloch, S. Mulé, A. Misra, 1974, The Journal of pharmacology and experimental therapeutics.

Disposition and metabolism of [3H] cocaine in acutely and chronically treated monkeys.

V. V. Giri, M. Patel, S. Mulé, 1977, Drug and alcohol dependence.

Laeve-[1-3H]Methadone disposition in tolerant dogs.

R. Bloch, S. Mulé, A. Misra, 1975, Xenobiotica; the fate of foreign compounds in biological systems.

Some physicochemical and pharmacological properties of morphine‐2,3‐quinone, the morphine metabolite in the rat brain

S. Mulé, A. Misra, N. L. VADLAMANI, 1974, The Journal of pharmacy and pharmacology.

Physiological disposition and biotransformation of l-alpha-[2-3H]acetylmethadol (LAAM) in acutely and chronically treated monkeys.

R. Bloch, T. R. Bates, S. Mulé, 1978, The Journal of pharmacology and experimental therapeutics.

Rendering the "poppy-seed defense" defenseless: identification of 6-monoacetylmorphine in urine by gas chromatography/mass spectroscopy.

S. Mulé, G. Casella, 1988, Clinical chemistry.

Intracellular disposition of (3H)-cocaine, (3H)-norcocaine, (3H)-benzoylecgonine and (3H)-benzoylnorecgonine in the brain of rats.

S. Mulé, G. Casella, A. Misra, 1976, Life sciences.

A quick, qualitative assay for alcohol in urine.

K. Verebey, S. Mulé, 1986, Journal of analytical toxicology.

The preparation of tritium nuclear-labeled morphine and evidence for its in vivo biotransformation to normorphine in the rat.

L. A. Woods, S. Mulé, A. Misra, 1961, The Journal of pharmacology and experimental therapeutics.

Stereoselectivity and Differential Metabolism in vivo of Dextro and Laevo-Methadone-1-3H

S. Mulé, A. Misra, 1973, Nature.

Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine.

S. Mulé, A. Misra, N. L. Vadlamani, 1976, The Journal of pharmacology and experimental therapeutics.

Cocaine Metabolite) in Human Urine

A. Pace, K. Verebey, S. Mulé, 1977 .

Disposition and metabolism of [3H]pseudomorphine in the rat

S. Mulé, A. Misra, 1972 .

Pharmacokinetics and metabolism of l-alpha-[O,O'-3H2]-acetyl normethadol (nor-LAAM), the active metabolite of LAAM, in acutely and chronically treated rhesus monkeys.

R. Bloch, T. R. Bates, S. Mulé, 1980, The Journal of pharmacology and experimental therapeutics.

Comparative effects of cocaine and pseudococaine on EEG activities, cardiorespiratory functions, and self-administration behavior in the rhesus monkey

M. Matsuzaki, S. Mulé, P. J. Spingler, 1978, Psychopharmacology.

Cocaine and metabolites: Relationship between pharmacological activity and inhibitory action on dopamine uptake into striatal synaptosomes

S. Mulé, D. Clouet, N. Williams, 1977 .

METHODOLOGICAL PROBLEMS IN DRUG INTERACTIONS

S. Mulé, 1976, Annals of the New York Academy of Sciences.

Methods for the analysis of morphine and related surrogates: current status.

S. Mulé, 1974, Journal of chromatographic science.

Differential pharmacokinetic and metabolic profiles of the stereoisomers of 3-hydroxy-N-methyl morphinan.

R. Bloch, S. Mulé, A. Misra, 1974, Research communications in chemical pathology and pharmacology.

Chromatographic separation of methadone, some of its metabolites and congeners.

S. Mulé, A. Misra, N. L. Vadlamani, 1972, Journal of chromatography.

The specificity of binding of the narcotic agonist etorphine in synaptic membranes of rat brain in vivo

S. Mulé, G. Casella, D. Clouet, 1975, Psychopharmacologia.

One hundred EMIT positive cannabinoid urine samples confirmed by BPA/TLC, RIA, and GC/MS.

M. Lehrer, K. Verebey, S. Mulé, 1986, Journal of analytical toxicology.

Relationship of pharmacokinetic and metabolic parameters to the absence of physical dependence liability with thebaine-3H

S. Mulé, A. Misra, R. Pontani, 1973, Experientia.

Confirmation of EMIT benzodiazepine assay with GLC/NPD.

K. Verebey, S. Mulé, D. Jukofsky, 1982, Journal of analytical toxicology.